GitLab
GTLB Nasdaq Application Software Financials FY2020–FY2026
GitLab's revenue rose 25.8% to $955 million in fiscal 2026. Its operating margin was −7.4%, up from −18.8% a year earlier. Free cash flow was $222 million. The diluted share count rose 3.9%.
About these figures. GitLab has no borrowings, so debt is counted as zero.
What GitLab does
No business description yet.
- Legal name
- GITLAB INC.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- —
- Accession · CIK
- 0001628280-26-018731
0001653482
Revenue and margins
GitLab had $955M of revenue in fiscal 2026, up 25.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $222M in fiscal 2026, 23.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
GitLab returned $0.0M to shareholders in fiscal 2026, 0% of free cash flow. The diluted share count rose 3.9%.
Value GitLab yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of $1.3B and divides by 166.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably GitLab can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $935M | $937M | $1.0B | $992M | $1.3B |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 4.4x | 3.7x | 1.9x | 2.5x | 2.5x |
| Quick ratio | 4.4x | 3.7x | 1.9x | 2.5x | 2.5x |
| Total assets | $1.1B | $1.2B | $1.3B | $1.4B | $1.7B |
| Total liabilities | $292M | $345M | $715M | $578M | $687M |
| Shareholders' equity | $775M | $771M | $560M | $776M | $991M |
| Net debt (− = net cash) | −$935M | −$937M | −$1.0B | −$992M | −$1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.3M
1 insider
Sold, 12 months
$119M
4 insiders
Of sales under plans
99%
$119M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Sytse SijbrandijDirector | Sold plan | 116,200 | $53.27 | $6.2M | Form 4 |
| Sep 28, 2026 | Sivaprasad PadisettyChief Technology Officer | Sold plan | 51,915 | $45.78 | $2.4M | Form 4 |
| Sep 28, 2026 | Sytse SijbrandijDirector | Sold plan | 430,000 | $45.84 | $19.7M | Form 4 |
| Sep 25, 2026 | Sytse SijbrandijDirector | Sold plan | 705,490 | $47.75 | $33.7M | Form 4 |
| Sep 24, 2026 | Sytse SijbrandijDirector | Sold plan | 980,710 | $48.63 | $47.7M | Form 4 |
| Aug 7, 2026 | Simon MundyChief Accounting Officer | Sold plan | 8,725 | $38.00 | $0.3M | Form 4 |
| Jun 30, 2026 | William StaplesChief Executive Officer, Director | Bought plan | 4,188 | $29.36 | $0.1M | Form 4 |
| Jun 15, 2026 | Sytse SijbrandijDirector | Sold plan | 116,200 | $28.44 | $3.3M | Form 4 |
| May 18, 2026 | Sytse SijbrandijDirector | Sold plan | 116,200 | $24.85 | $2.9M | Form 4 |
| Apr 15, 2026 | Sytse SijbrandijDirector | Sold plan | 116,200 | $20.77 | $2.4M | Form 4 |
| Mar 31, 2026 | William StaplesChief Executive Officer, Director | Bought plan | 6,010 | $21.35 | $0.1M | Form 4 |
| Mar 27, 2026 | Susan L BostromDirector | Sold | 32,500 | $20.36 | $0.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✕ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ |
| Debt fell relative to assets | ✕ | ✕ | ✕ |
| Current ratio rose | ✕ | ✓ | ✓ |
| Share count didn't rise | ✕ | ✕ | ✕ |
| Gross margin rose | ✓ | ✕ | ✕ |
| Revenue rose relative to assets | ✓ | ✓ | ✓ |
| F-score | 4 / 9 | 3 / 9 | 4 / 9 |
| Accruals ratio | −37.0% | 4.2% | −18.5% |
| Altman Z'' | 0.09 | 1.80 | 2.82 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| GitLab GTLB | $9.5B | 25.8% | −7.4% | 23.2% | — | — | 4 | |
| AppFolio APPF | $7.5B | 19.7% | 16.1% | 25.1% | 50.3% | 44.4x | 4 | Compare → |
| Manhattan Associates MANH | $14.1B | 3.8% | 25.9% | 34.6% | — | 68.5x | 6 | Compare → |
| Asana ASAN | $2.8B | 9.3% | −25.0% | 11.0% | — | — | — | Compare → |
| Dolby DLB | $5.9B | 5.9% | 19.6% | 32.3% | 11.4% | 26.7x | 5 | Compare → |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $81.2M | $152M | $253M | $424M | $580M | $759M | $955M |
| Gross profit | $71.9M | $134M | $223M | $373M | $520M | $674M | $835M |
| Research and development | $59.4M | $107M | $97.2M | $156M | $201M | $240M | $275M |
| Operating income | −$128M | −$214M | −$129M | −$211M | −$187M | −$143M | −$70.5M |
| Pretax income | −$130M | −$189M | −$159M | −$175M | −$161M | −$85.8M | −$48.1M |
| Income tax | $1.2M | $2.8M | −$1.5M | $4.0M | $265M | −$76.7M | $10.5M |
| Net income | −$131M | −$192M | −$155M | −$173M | −$426M | −$6.3M | −$56.0M |
| Diluted EPS | −$2.76 | −$3.82 | −$1.95 | −$1.17 | −$2.76 | −$0.04 | −$0.34 |
| Diluted shares | 0.05B | 0.05B | 0.08B | 0.15B | 0.15B | 0.16B | 0.17B |
| Cash flow | |||||||
| Cash from operations | −$60.2M | −$73.6M | −$49.8M | −$77.4M | $35.0M | −$64.0M | $233M |
| Capital expenditure | $0.0M | $0.0M | $3.5M | $6.1M | $1.6M | $3.8M | $10.8M |
| Free cash flow | −$60.2M | −$73.6M | −$53.4M | −$83.5M | $33.4M | −$67.7M | $222M |
| Depreciation and amortization | $0.0M | $0.0M | $0.5M | $3.2M | $4.4M | $2.9M | $3.3M |
| Stock-based compensation | $40.9M | $112M | $30.0M | $123M | $163M | $186M | $215M |
| Acquisitions | $0.0M | $0.0M | $0.3M | $0.0M | $0.0M | $20.2M | $0.0M |
| Share buybacks | $0.0M | $0.8M | $0.6M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.8M | $0.6M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $343M | $283M | $935M | $937M | $1.0B | $992M | $1.3B |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | — | $349M | $1.1B | $1.1B | $1.3B | $1.3B | $1.7B |
| Current liabilities | — | $127M | $242M | $306M | $677M | $545M | $652M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | — | $0.0M | $3.3M | $5.8M | $3.0M | $4.0M | $11.8M |
| Total assets | — | $363M | $1.1B | $1.2B | $1.3B | $1.4B | $1.7B |
| Total liabilities | — | $169M | $292M | $345M | $715M | $578M | $687M |
| Shareholders' equity | −$135M | −$231M | $775M | $771M | $560M | $776M | $991M |
| Margins | |||||||
| Gross margin | 88.5% | 87.9% | 88.1% | 87.8% | 89.7% | 88.8% | 87.4% |
| Operating margin | −158.0% | −140.6% | −51.0% | −49.8% | −32.3% | −18.8% | −7.4% |
| EBITDA margin | −158.0% | −140.6% | −50.8% | −49.1% | −31.6% | −18.4% | −7.0% |
| Net margin | −161.0% | −126.3% | −61.4% | −40.9% | −73.4% | −0.8% | −5.9% |
| FCF margin | −74.1% | −48.4% | −21.1% | −19.7% | 5.8% | −8.9% | 23.2% |
| Returns | |||||||
| Return on capital employed | — | — | −23.8% | −24.7% | −24.9% | −19.1% | −7.3% |
| Return on equity | — | — | −57.1% | −22.4% | −64.0% | −1.0% | −6.3% |
| Return on assets | — | — | −21.3% | −15.3% | −34.2% | −0.5% | −3.6% |
| Growth | |||||||
| Revenue growth | — | 87.4% | 66.0% | 68.0% | 36.7% | 30.9% | 25.8% |
| FCF growth | — | — | — | — | — | −302.6% | — |
| Share count change | — | 6.4% | 58.4% | 86.1% | 4.0% | 4.1% | 3.9% |
| Financial health | |||||||
| Debt / equity | — | — | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | — | 2.7x | 4.4x | 3.7x | 1.9x | 2.5x | 2.5x |
| Quick ratio | — | 2.7x | 4.4x | 3.7x | 1.9x | 2.5x | 2.5x |
| Capital allocation | |||||||
| Capex / revenue | 0.0% | 0.0% | 1.4% | 1.4% | 0.3% | 0.5% | 1.1% |
| Stock comp / revenue | 50.3% | 73.5% | 11.9% | 28.9% | 28.1% | 24.5% | 22.5% |
| Payouts / FCF | — | — | — | — | 0.0% | — | 0.0% |
| Quality scores | |||||||
| Piotroski F-score | — | — | — | 2.0 | 4.0 | 3.0 | 4.0 |
| Altman Z'' | — | −5.0 | 5.3 | 3.8 | 0.1 | 1.8 | 2.8 |
| Accruals ratio | — | — | −14.5% | −8.5% | −37.0% | 4.2% | −18.5% |
Source: SEC EDGAR XBRL filings (CIK 0001653482). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.